The side effects of semaglutide are often mild, and may not be experienced by all
As research continues to unfold, the fertility implications of GLP-1 treatments are likely to remain a focal point in both clinical and legal contexts
Conclusion Managing semaglutide injections and other routes effectively requires vigilance in avoiding interactions with incompatible drugs, supplements, and foods
Abstract Background: The purpose of this study was to explore how semaglutide, a GLP-1RA, regulates serum metabolism and gut microbiota to improve obesity in mice and whether fecal microbiota transplantation (FMT) can transmit the beneficial effects of semaglutide to recipient mice
There is no FDA guidance supporting routine every-other-week dosing as a maintenance strategy
however, patients with advanced disease should be monitored vigilantly